Page last updated: 2024-10-20

trimethylamine and Ischemic Attack, Transient

trimethylamine has been researched along with Ischemic Attack, Transient in 1 studies

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research Excerpts

ExcerptRelevanceReference
"There is increasing evidence for the association of trimethylamine-N-oxide (TMAO) with cognitive impairment after minor stroke or transient ischemic attack (TIA)."4.31Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack. ( Bao, Y; Huang, D; Jiang, L; Qv, S; Wang, J; Wang, L; Xu, G; Yang, J; Zhan, X, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, L1
Zhan, X1
Jiang, L1
Xu, G1
Bao, Y1
Wang, J1
Qv, S1
Yang, J1
Huang, D1

Other Studies

1 other study available for trimethylamine and Ischemic Attack, Transient

ArticleYear
Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack.
    Neurological research, 2023, Volume: 45, Issue:7

    Topics: Aged; Cognitive Dysfunction; Humans; Ischemic Attack, Transient; Male; Oxides; Retrospective Studies

2023